BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28571246)

  • 1. A Comparative Analysis of Two Different Dose Fractionation Regimens of High Dose Rate Intracavitary Brachytherapy in Treatment of Carcinoma of Uterine Cervix: A Prospective Randomized Study.
    Rao BS; Das P; Subramanian BV; Jena A; Rashmi P; Konakalla VLA; Jayasree K
    J Clin Diagn Res; 2017 Apr; 11(4):XC06-XC10. PubMed ID: 28571246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study between two different dose fractionation schedules of cobalt-60-based HDR intracavitary brachytherapy in carcinoma cervix stages IIB-IIIC1.
    Gagrani V; Kabara J; Shukla A; Rathore NK; Rajpurohit VS; Jangid PK; Manna S
    J Cancer Res Ther; 2024 Jan; ():. PubMed ID: 38261446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.
    Gupta IJ; Ghosh A; Yadav J; Tuteja JS; Gupta R; Srivastava K; Verma M; Gupta S; Srivastava S; Bhatt MLB
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3441-3445. PubMed ID: 37898849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dose-Rate Orthogonal Intracavitary Brachytherapy with 9 Gy/Fraction in Locally Advanced Cervical Cancer: Is it Feasible??
    Ghosh S; Rao P
    J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):452-8. PubMed ID: 27651645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two high dose rate intracavitary brachytherapy regimens in treatment of cervical cancer: a preliminary report.
    Krishna A; Hasib AG; Fernandes D; Athiyamaan MS; Rao S; Shankar S; Ali M; Priyadarshini H; Sophia M; Shridhar CH; George S; Babu A; Banerjee S; Sunny J; Srinivas C; Lobo D
    Discov Oncol; 2023 Mar; 14(1):33. PubMed ID: 36988721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsed-dose-rate vs. high-dose-rate intracavitary radiotherapy for locally advanced carcinoma of cervix: A prospective randomized study.
    Kumar P; Sharma DN; Kumar S; Gandhi AK; Rath GK; Julka PK
    Brachytherapy; 2016; 15(3):327-332. PubMed ID: 26996595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
    Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
    Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
    Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of high-dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix.
    Patel FD; Kumar P; Karunanidhi G; Sharma SC; Kapoor R
    Brachytherapy; 2011; 10(2):147-53. PubMed ID: 20685179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens.
    Le Pechoux C; Akine Y; Sumi M; Tokuuye K; Ikeda H; Yajima M; Yamada T; Tanemura K; Tsunematsu R; Ohmi K
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):735-41. PubMed ID: 7860384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial.
    Mahantshetty U; Lewis S; Engineer R; Swamidas J; Chopra S; Gurram L; Kinhikar R; Deshpande D; Kirisits C; Shrivastava S
    Brachytherapy; 2021; 20(6):1146-1155. PubMed ID: 34598883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
    Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.